Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Blood Transfusion = Trasfusione Del Sangue
|
November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia A
Sebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors
Miguel Escobar, James Luck, Yevhenii Averianov, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors
Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Research Square
|
October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Tom Howard, Marcio Almieda, Vincent Diego, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Blood Transfusion = Trasfusione Del Sangue
|
November 29, 2016
Summary report of the First International Conference on inhibitors in haemophilia A
Sebastien Lacroix-Desmazes, David W Scott, Jenny Goudemand, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors
Miguel Escobar, James Luck, Yevhenii Averianov, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 12, 2021
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors
Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, et al.
Research Square
|
October 27, 2023
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Tom Howard, Marcio Almieda, Vincent Diego, et al.
Blood
|
September 14, 2019
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek, et al.
Page
of 5